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Cognitive defects and neurological diseases represent a
major issue for human health,especially in aging popu-
lations. An estimated 15% of people >65 years are
affected by mild-to-severe conditions of genetic origin
affecting the central nervous system.Etiological factors
of common neurological and psychiatric disorders
remain elusive, apart from a few genes associated with
rare disorders, such as one form of Alzheimer’s disease
(APP),a form of amyotrophic lateral sclerosis (SOD1),
expanded polyglutamine track in Huntington’s disease,
and several types of ataxia or ion channel–associated
conditions.With the human DNA sequence unveiled as
a huge book of 3 gigabases,
1,2 how can we exploit the
genome readout to identify disease-associated alleles
and what is the projected impact for clinical genetics?
The “book of life”is complete to >90% of euchromatic
gene-rich regions, opening unprecedented possibilities
for the characterization of all genes. The emerging
human catalogue is thought to contain about 30 000
genes.Until now,factors underlying inherited conditions
were mostly identified by positional cloning without
prior knowledge of their biochemical function, and the
catalogue unlocks the door to fast in silico searching
(Figure 1,Part I).
Complex molecular processes govern organogenesis
and fitness builds upon the correct orchestration of
gene actions throughout life. Most clinical phenotypes
result from alterations of genetic instructions perturb-
ing this tightly regulated system, while being strongly
influenced by individual genetic makeup. The pro-
found transition seen with the sequence information is
the ability to foster novel concepts in our way of
addressing biology as a global entity. Comprehensive
studies of genome landscape and common polymor-
phisms will help identify causal and susceptibility fac-
tors at a much greater pace (Figure 1, Parts II and III).
Although 60% of human genes have no characterized
function yet,the sequence provides a body of informa-
tion for the design of global strategies in functional
genomics, for instance, using molecular evolution to
underpin function by inference. Comparative
genomics is one of the most powerful approaches to
deciphering the molecular basis of disease pathogene-
sis (Figure 2).
Another essential approach to extracting biological
meaning from the genetic message is illustrated by
global transcriptome analysis (Figure 3). Grasping how
global gene expression is processed into phenotype
will be essential to any progress in molecular medicine.
Hunting for disease-associated alleles by surveying
dynamic biological systems at all relevant develop-
mental stages and in all relevant tissues brings novel
perspectives that will allow the correlation of molecu-
lar phenotype with clinical phenotype.
Perspectives 
Dissecting the complex genetic architecture of com-
mon diseases represents a massive endeavor that will
profoundly influence the next decades of research in
molecular medicine. The strategic approaches
described here will become incredibly informative
when integrated with proteosome studies clinical
records, neuroimaging data, and physiology. Genome
research and bioinformatics are the cement bridging
all these disciplines together toward the establishment
of disease profiles, from molecules to phenotypes, for
assessing disease susceptibility, developing accurate
diagnosis, and novel personalized treatments.Candidates guessed from their
function and/or position in the
human gene catalogue 
Candidates guessed from their
function and/or position in the
human gene catalogue 
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Figure 1. The human genome catalogue unlocks the door to fast in silico searching and the design of novel high-throughput genotyping strategies.
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I. Linkage analysis or genome-wide scanning followed by positional/in silico cloning strategy
II. Assessing the impact of common sequence variants (SNPs) on phenotypic traits
III. Identification of susceptibility factors in complex disorders
Gene predictions using computer programs
• Monogenic disorders, when a single gene is necessary and sufficient to
cause a disease
- Rare genetic disorders with a mendelian pattern of inheritance
- Genetic instabilities (eg, triplet expansion in neurodegenerative conditions,
such as Huntington disease)
• Disease loci mapped by chromosomal rearrangements (eg, translocation
breakpoints in cancer)
• Modifying factors associated with multifactorial diseases (in rare cases when
mapping was possible)
May 2001: 1500 phenotypes were mapped and 1100
disease genes identified in the Online Mendelian
Inheritance in Man database (OMIM)
3
• 343 listed phenotypes match the keywords “mental
retardation” (168), “psychiatric” (21), or “neurologic”
(154).
4
• Sequence information expedites positional cloning
strategies, shifting from prior gene-finding methods
(eg, exon trapping, cDNA selection) to “in silico
cloning,” by scanning critical regions for known genes
or novel predicted genes. Matching cDNA sequences
and clones are often available from distribution cen-
ters,
5 bypassing tedious cloning steps for the users.
With the gene structure information at hand, muta-
tions can be searched effectively, also for those genet-
ic lesions falling outside of coding regions (splice, reg-
ulation sites, etc). 
Single nucleotide polymorphisms (SNPs) are distributed
across the genome. Dense and precise SNP maps will pave
the way to indexing global haplotype variations, essential
bases for population genetics, and epidemiological studies 
1.42 million SNPs in the genome; 
only 60 000 SNPs in exons
6
Most common diseases, including behavior and psychiatric disorders,
show a complex inheritance pattern resulting of subtle interactions
between several genetic loci and environmental factors. Linkage is often
not possible since the penetrance effect of individual genes is not large
enough. Allelic association can detect genes that account for as little as
1% of the variance in a given trait; polymorphisms with phenotypic asso-
ciations allow the identification of individual variations in the genome
and the assesment of the contribution of different genes in different fam-
ilies. The human sequence, the availability of SNP maps, and novel high-
throughput genotyping systems will boost the power of association
studies using large cohorts, allowing the analysis of multiple variations
for locating quantitative trait loci (QTL) components. Deciphering genet-
ic repertoires is a key step to understanding how variations in our genet-
ic program influence disease development, progression, and behavior. 
The challenge for the next decade will be to establish a genetic risk or pre-
disposition profiling for complex diseases. However, this approach has
intrinsic limitations. Progress on the genetics of complex diseases will large-
ly come from the analysis of animal models recapitulating human patho-
genic traits (see next page).
Disease-modifying factors
Linkage disequilibrium
Chromosomal 
location
Disease-associated SNPThe complete DNA sequences of about 60 prokaryotic and eukaryotic
organisms are now available. Comparing genomic sequences of different
species helps to identify genes, since protein-coding exons are usually
more conserved than the rest of the genome. Comparative mapping is
used for establishing correspondence of disease loci.
8 Mapping of genes in
one species often allows the identification and testing of the correspond-
ing genes in humans as candidates for involvement in a disease. Besides,
the networks of processes disturbed in a disease can only be understood
by using powerful genetic tools available in model organisms like mouse
or even in the evolutionarily distant Drosophila melanogaster or
Caenorhabditis elegans. Since a number of functional networks have
been remarkably conserved during evolution, the transfer of data from
model organisms to humans represents an efficient route to elucidating
the molecular basis of genetic diseases. For instance, striking parallels
between human, mouse, and Drosophila are observed for genes involved
in the development of the central nervous system (eg, sonic, Gli). Further
information can be found in specific genome databases; the main
addresses are listed on the Internet.
9
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Figure 2. Genome sequences boost the power of model organisms and comparative genomics for identifying disease genes and under-
standing their function.
Human
diseases
The large mutant collections obtained in Drosophila rep-
resent a breakthrough for deciphering gene function, in
pathways involved in development and neurogenesis.
7
Animal models—spontaneous or engineered mutants
(eg, knockout)—are essential tools for dissecting compo-
nents of complex diseases. Mouse genetics allows the
mapping of candidate genes (quantitative trait loci), and
back testing of orthologous genes in patient cohorts.61
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Figure 3. Global analysis of the transcriptome by complex hybridization on assays: identifying and spotting all of the ≈ 16 000 to 20 000 genes
that could be expressed in the human brain.
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Transcript profiling and molecular phenotyping: chip-based strategies
allow the monitoring of variations of gene expression in affected tissues
(eg, brain regions) by analyzing several thousands genes at a time;
anatomical maps of gene expression can be established. Genes that are
either down- or upregulated in a given condition will identify a pool of
potential candidates. Relevant cDNAs are isolated from their original
array position, giving immediate access to cloned material. This
approach provides essential entry points for dissecting the molecular
basis of disease pathogenesis and deciphering affected pathways.
Global transcript profiles can help stratifying patient samples according
to their molecular phenotypes and defining disease-specific subtypes,
eg, to classify cancer subtypes. 
Human genome ≈ 30 000 genes
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